Thus, these results suggest that cisplatin-induced m6A methylation of DDB2 and XPC leads to stabilization of their mRNA, which can be further augmented by the KRAS mutant in NSCLC cells. This evidence concerns the gene DDB2 and non-small cell lung carcinoma.